Edward J. Stewart - Net Worth and Insider Trading
Edward J. Stewart Net Worth
The estimated net worth of Edward J. Stewart is at least $32,363 dollars as of 2024-11-13. Edward J. Stewart is the Head of Commercial of Merrimack Pharmaceuticals Inc and owns about 2,139 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $32,363. Details can be seen in Edward J. Stewart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward J. Stewart has not made any transactions after 2016-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Edward J. Stewart
Edward J. Stewart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward J. Stewart owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Edward J. Stewart’s form 4 insider trades.
Insider Ownership Summary of Edward J. Stewart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-01-05 | SVP & Pres & Healthcare Sol |
Edward J. Stewart Latest Holdings Summary
Edward J. Stewart currently owns a total of 1 stock. Edward J. Stewart owns 2,139 shares of Merrimack Pharmaceuticals Inc (MACK) as of January 5, 2016, with a value of $32,363.
Latest Holdings of Edward J. Stewart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-01-05 | 2,139 | 15.13 | 32,363 |
Holding Weightings of Edward J. Stewart
Edward J. Stewart Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward J. Stewart has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 400 shares on January 5, 2016, which brought Edward J. Stewart around $32,000.
Insider Trading History of Edward J. Stewart
- 1
Edward J. Stewart Trading Performance
Edward J. Stewart Ownership Network
Ownership Network List of Edward J. Stewart
Ownership Network Relation of Edward J. Stewart
Edward J. Stewart Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Edward J. Stewart is the SVP & Pres & Healthcare Sol of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Edward J. Stewart made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 446,418 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 450,418 shares were bought by its insiders, resulting in a net purchase of 450,418 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Edward J. Stewart Mailing Address
Above is the net worth, insider trading, and ownership report for Edward J. Stewart. You might contact Edward J. Stewart via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
